What is Foundayo? A Complete Guide to the Oral Weight Loss Medication

Foundayo™ (orforglipron) is Eli Lilly's newly FDA-approved oral glucagon-like peptide-1 (GLP-1) medication for weight loss, and it's the first GLP-1 tablet that can be taken at any time of day without food or water restrictions. That flexibility sets it apart from every other option currently available.

Found is not affiliated with or endorsed by Eli Lilly and Company, the manufacturer of Zepbound®, Mounjaro®, Foundayo™, and other GLP-1 medications.

Here's what you need to know about how Foundayo works, its effectiveness in clinical trials, side effects to watch for, and how it compares with other FDA-approved weight loss medications.

What is Foundayo™?

Foundayo (orforglipron) is a newly FDA-approved, once-daily oral glucagon-like peptide-1 (GLP-1) agonist developed by Eli Lilly for chronic weight management. As a small molecule, non-peptide medication, Foundayo offers something no other oral GLP-1 medication does: it can be taken at any time of day without food or water restrictions.

The FDA approved Foundayo on April 1, 2026, for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who have at least one weight-related health condition, addressing a population where 40.3% of US adults have obesity. Unlike supplements or over-the-counter products, Foundayo is a prescription medication that requires evaluation by a licensed clinician.

• Brand name: Foundayo (pronounced fown-DAY-oh)
• Generic name: orforglipron
• Medication class: GLP-1 agonist (small molecule, non-peptide)
• Manufacturer: Eli Lilly
• Form: Once-daily oral tablet

How Foundayo works

GLP-1 receptor activation

Your body naturally produces a hormone called GLP-1 after you eat, and medications that mimic this hormone have become a US$ 58.05 billion market by 2026. GLP-1 helps regulate blood sugar and tells your brain you're full. Foundayo mimics this hormone by activating the same receptors, essentially amplifying a process your body already uses.

Here's what makes Foundayo different from injectable GLP-1s: most GLP-1 medications are large peptide molecules that get destroyed by stomach acid, which is why they're given as injections. Foundayo is a small molecule designed to survive the digestive process and still activate GLP-1 receptors effectively.

Effects on appetite and metabolism

When Foundayo activates GLP-1 receptors, a few things happen. Appetite decreases. Feelings of fullness increase. The stomach empties more slowly, which helps you feel satisfied longer after meals.

The result? Many people find they're satisfied with smaller portions and experience fewer cravings between meals. That said, individual responses vary. Some people notice appetite changes within the first few weeks, while others take longer to experience the full effects.

How effective is Foundayo for weight loss

Clinical trial results

In the ATTAIN-1 and ATTAIN-2 clinical trials, participants taking Foundayo experienced meaningful weight loss compared with placebo. In clinical trials, participants taking the highest dose of Foundayo lost an average of 15–17% of their body weight over 36 to 72 weeks, compared to roughly 2% in the placebo group. One important detail: trial participants combined Foundayo with a reduced-calorie diet and increased physical activity.

One important detail: trial participants combined Foundayo with a reduced-calorie diet and increased physical activity. The medication works best as part of a comprehensive approach to weight care, not as a standalone solution.

Expected weight loss timeline

Weight loss typically begins within the first few weeks of treatment, though the pace differs from person to person. Factors like starting weight, metabolic health, diet, physical activity, and medication adherence all play a role.

The goal isn't rapid weight loss. It's sustainable, gradual progress. Many people continue to see results over several months as they titrate to higher doses and their bodies adjust.

How to take Foundayo

Daily dosing

Foundayo is taken once daily as an oral tablet. You can take it in the morning, at night, or whenever fits your routine. There's no need to plan your dose around meals or wait before eating.

No food or water restrictions

This flexibility is Foundayo's defining feature among oral GLP-1 options. Rybelsus® (oral semaglutide), for example, requires taking it on an empty stomach with no more than 4 ounces of water, then waiting at least 30 minutes before eating, drinking, or taking other medications.

Foundayo eliminates all of that. Foundayo is "enzymatically stable," meaning it doesn't get "digested" like a protein. For people with busy or unpredictable schedules, this convenience may make it easier to stay consistent with treatment.

Dose titration schedule

Clinicians typically start patients at a lower dose (0.8 mg) and gradually increase it over several weeks or months. This "start low, go slow" approach helps the body adjust and minimizes potential side effects.

Your prescribing clinician will determine the right titration schedule based on how you respond and tolerate each dose level.

Foundayo side effects and safety

Common side effects

The most frequently reported side effects are gastrointestinal, similar to other GLP-1 medications. Side effects tend to be most noticeable during dose increases and often lessen as the body adjusts.

• Nausea: Often temporary and improves over time
• Diarrhea: Usually mild to moderate
• Vomiting: More common during dose titration
• Constipation: May occur in some people
• Stomach discomfort: Typically decreases with continued use

Serious side effects to watch for

Though less common, some side effects require immediate medical attention. Severe stomach pain that doesn't go away could signal pancreatitis. Gallbladder problems and severe allergic reactions are also possible.

Foundayo carries a boxed warning about a potential risk of thyroid C-cell tumors. The medication is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). As with all medications in the GLP-1 class, Foundayo includes safety labeling regarding thyroid risks observed in animal studies.

Tips for managing side effects

Eating smaller, more frequent meals can help reduce nausea. Staying well-hydrated is also important, especially if you experience diarrhea.

Most importantly, communicate with your prescribing clinician about any symptoms. Clinicians can adjust your titration schedule or provide additional guidance. Many people find that side effects are most noticeable in the first few weeks of a new dose and improve with time.

Foundayo vs other FDA-approved GLP-1 medications

Foundayo vs Zepbound

Both medications come from Eli Lilly, but they differ in important ways. Foundayo is a daily pill, while Zepbound is a weekly injection. They also work differently: Foundayo targets only GLP-1 receptors, while Zepbound is a dual agonist that targets both GLP-1 and GIP receptors.

Some people prefer the convenience of a once-daily tablet. Others find a once-weekly injection easier to remember. The choice often comes down to personal preference and lifestyle.

Foundayo vs Wegovy Pill

Both Foundayo and Wegovy pill are oral GLP-1 options, but their dosing requirements differ significantly. Oral semaglutide, which is used for metabolic health and weight management, must be taken on an empty stomach with a small amount of water, followed by a 30-minute wait before eating or drinking anything else.

Foundayo, on the other hand, offers more flexibility. It can be taken at any time of day, with or without food, without the need for strict timing or fasting requirements.

For people who find it difficult to follow rigid medication routines, Foundayo’s simplicity may make it a more practical and sustainable option.

Foundayo vs injectable GLP-1s

The primary difference is administration. Some people strongly prefer avoiding injections, making Foundayo appealing. Others find a once-weekly injection more convenient than remembering a daily dose.

Both approaches can be effective. The best choice depends on your preferences, lifestyle, and what you're most likely to stick with long term.

Who qualifies for Foundayo

BMI and weight requirements

Foundayo is FDA-approved for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who have at least one weight-related health condition. BMI, or body mass index, is a measure of body fat based on height and weight.

Health conditions that may increase eligibility

For adults with a BMI of 27 or higher, having one of the following weight-related conditions may qualify you for a prescription:

• Type 2 diabetes
• High blood pressure (hypertension)
• High cholesterol (dyslipidemia)
• Heart disease
• Obstructive sleep apnea

Who should not take Foundayo

A clinician will evaluate your full medical history before prescribing. Foundayo is not appropriate for people with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, or a known allergy to orforglipron. The medication is also not recommended during pregnancy or breastfeeding.

How much does Foundayo cost

List price and self-pay options

Like other brand-name GLP-1 medications, Foundayo has a manufacturer list price that can be significant without insurance. However, Eli Lilly offers direct-to-patient access through LillyDirect, which may provide more transparent pricing and self-pay options for eligible patients.

Savings programs or bundled pricing may be available through LillyDirect or participating pharmacies. Because pricing and eligibility can vary, it’s best to check current options through LillyDirect, your clinician, or your pharmacy.

Insurance coverage for Foundayo

Coverage for weight loss medications varies widely by insurance plan. Some plans cover GLP-1 medications; others don't, with only 19% of large employers covering GLP-1 drugs for weight loss. Many require prior authorization before approving coverage.

Checking your benefits before starting treatment can help you avoid surprises. Some telehealth weight care platforms offer tools to verify insurance coverage for GLP-1 medications before you commit to treatment.

How to get started with Foundayo

Foundayo requires a prescription from a licensed clinician. The process typically involves a medical evaluation where a clinician reviews your health history, current medications, and weight-related conditions. Based on this assessment, the clinician determines whether Foundayo is appropriate for you.

If prescribed, you'll receive guidance on dosing and a plan for ongoing support, including regular follow-ups to monitor progress and adjust treatment as needed. Telehealth platforms specializing in weight care can provide virtual consultations with licensed clinicians experienced in weight care, making it convenient to explore whether medications like Foundayo might be right for you.

For those exploring weight loss medication options, working with weight care specialists can help determine the right approach. Found is among the largest medically-supported telehealth weight care platforms in the country, having served more than 250,000 members to date. To discover your MetabolicPrint™ and start your journey with Found, take our quiz. *Individual results may vary.

FAQs about Foundayo

Can I switch from an injectable GLP-1 to Foundayo?

Switching between GLP-1 medications is possible but requires clinician guidance. Your clinician will help manage the transition and determine appropriate dosing based on your current treatment.

Does Foundayo need to be refrigerated?

No. Foundayo is stored at room temperature, unlike some injectable GLP-1 medications that require refrigeration. This makes it easier to travel with and store.

Can I take Foundayo if I have type 2 diabetes?

Foundayo may be prescribed for people with type 2 diabetes, though a clinician will evaluate whether it's appropriate based on your current diabetes medications and overall health.

How long do I need to take Foundayo for weight loss?

Weight loss medication is typically part of a long-term weight care plan. The duration depends on your individual goals, response to treatment, and ongoing discussions with your clinician. Sustainable weight care often involves continued support rather than a fixed endpoint.

Is Foundayo available through telehealth providers?

Yes. Foundayo can be prescribed through telehealth platforms that offer weight care services, allowing you to consult with clinicians virtually and receive a prescription if clinically appropriate.